Levobupivacaine for Axillary Brachial Plexus Block: A Pharmacokinetic and Clinical Comparison in Patients with Normal Renal Function or Renal Disease
Authors:
- James C. CrewsJCJames C. Crews
- Robert S. WellerRWRobert S. Weller
- Jonathan MossJMJonathan Moss
- Robert L. JamesRJRobert L. James
- 1 July 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 95 (1) , 219-223
Abstract
We compared the pharmacokinetics and clinical characteristics of 0.5% levobupivacaine for axillary block in patients with normal renal function versus patients with end-stage renal disease (ESRD). Twenty patients with normal renal function and eight patients with ESRD received an axillary block with 50–60 mL of 0.5% levobupivacaine. Patients were evaluated for onset and duration of sensory/motor block. Eleven patients with normal renal function and eight patients with ESRD underwent pharmacokinetic analysis. No differences between groups were found in the onset, duration, or quality of block. The median time to sensory block was 12.5 min and 12.9 min, and mean duration of the block was 19 h and 22 h in normal versus ESRD patients, respectively. No significant differences in noncompartmental pharmacokinetic variables (median) were found between normal and ESRD patients with an AUC0-t (μg · h−1 · mL−1) of 11 and 13, peak concentration (Cmax) (μg/mL) of 1.2 and 1.6, and a time to peak concentration (Tmax) (min) of 55 and 48, respectively. This study demonstrates the clinical efficacy and equivalence of the pharmacokinetic characteristics of 0.5% levobupivacaine for axillary brachial plexus block in patients with ESRD and normal renal function.Keywords
This publication has 13 references indexed in Scilit:
- A comparison of the cardiovascular effects of levobupivacaine and rac‐bupivacaine following intravenous administration to healthy volunteersBritish Journal of Clinical Pharmacology, 1998
- Cardiovascular and Central Nervous System Effects of Intravenous Levobupivacaine and Bupivacaine in SheepAnesthesia & Analgesia, 1998
- Stereoselective Block of Cardiac Sodium Channels by Bupivacaine in Guinea Pig Ventricular MyocytesCirculation, 1995
- Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomersBiophysical Journal, 1995
- Myocardial Uptake of BupivacaineAnesthesia & Analgesia, 1993
- CARDIOVASCULAR EFFECTS AND REGIONAL CLEARANCES OF I.V. BUPIVACAINE IN SHEEP: ENANTIOMERIC ANALYSISBritish Journal of Anaesthesia, 1991
- DISPOSITION OF MEPIVACAINE AND BUPIVACAINE ENANTIOMERS IN SHEEP †British Journal of Anaesthesia, 1991
- Stereoselective effects of the enantiomers of bupivacaine on the electrophysiological properties of the guinea‐pig papillary muscleBritish Journal of Pharmacology, 1991
- Plasma concentrations of bupivacaine after supraclavicular brachial plexus blockade in patients with chronic renal failureAnaesthesia, 1991
- Brachial Plexus Blockade and Chronic Renal FailureAnesthesiology, 1988